Levothyroxine sodium - IBSA

Drug Profile

Levothyroxine sodium - IBSA

Alternative Names: L-thyronine-sodium - IBSA; L-thyroxine-sodium - IBSA; Levothyroxine - IBSA; Levothyroxine sodium liquid gel capsules - IBSA; Levothyroxine sodium oral solution; Levothyroxine-sodium-I-125 - IBSA; LT4 - IBSA; Monosodium-L-thyroxine-hydrate - IBSA; T4 - IBSA; Thyroxine-I-125 - IBSA; Thyroxine-sodium - IBSA; Tirosint; Tirosint - IBSA; Tirosint-SOL

Latest Information Update: 17 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator IBSA
  • Developer Akrimax Pharmaceuticals; IBSA
  • Class Aromatic amino acids; Small molecules; Thyroid hormones
  • Mechanism of Action Thyroid hormone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypothyroidism

Most Recent Events

  • 15 Dec 2016 Registered for Hypothyroidism in USA (PO) (3227235; 9211568)
  • 30 May 2015 IBSA completes a phase II trial in Hypothyroidism (In volunteers) in Switzerland (ISRCTN12149022)
  • 21 Jan 2015 Phase II trials in Hypothyroidism (In volunteers) in Switzerland (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top